Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.34 |
| ▸ | FDPS | P14324 | 5/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4944335 | 0.98 | SMPD1 (0.39) | SMPD1TSHRTHRBDNM1MEN1 | |
| SCHEMBL8849917 | 0.80 | — | — | |
| SCHEMBL16616204 | 0.80 | SMPD1 (0.41) | SMPD1TSHRTHRBDNM1MEN1 | |
| SCHEMBL2200426 | 0.80 | SMPD1 (0.41) | SMPD1TSHRTHRBDNM1MEN1 | |
| SCHEMBL4582470 | 0.71 | SMPD1 (0.55) | SMPD1TSHRTHRBGGPS1FDPS | |
| SCHEMBL7523594 | 0.71 | SMPD1 (0.55) | SMPD1TSHRTHRBGGPS1FDPS | |
| SCHEMBL19390709 | 0.70 | TSHR (0.44) | SMPD1TSHRTHRBGGPS1FDPS | |
| SCHEMBL20819823 | 0.70 | TSHR (0.44) | SMPD1TSHRTHRBGGPS1FDPS | |
| SCHEMBL38663510 | 0.70 | TSHR (0.44) | SMPD1TSHRTHRBGGPS1FDPS | |
| SCHEMBL11253869 | 0.70 | TSHR (0.44) | SMPD1TSHRTHRBGGPS1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122095029-A | Molded article and curable composition | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260118791-A1 | TONER | CANON KK (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4086705-B1 | TONER | CANON KK (JP) | 2026-03-25 | — | — | EP | disclosed |
| EP-4012501-B1 | EXTERNAL ADDITIVE FOR TONER, TONER AND IMAGE FORMING APPARATUS | CANON KK (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-12487539-B2 | Fine particle, external additive for toners, and toner | CANON KABUSHIKI KAISHA (JP) | 2025-12-02 | — | — | US | disclosed |
| US-20250355380-A1 | TWO-COMPONENT DEVELOPER | CANON KK (JP) | 2025-11-20 | — | — | US | disclosed |
| US-20250334896-A1 | EXTERNAL ADDITIVE FOR TONER AND TONER | CANON KK (JP) | 2025-10-30 | — | — | US | disclosed |
| US-20250334892-A1 | FINE POWDER FOR TONER AND TONER | CANON KK (JP) | 2025-10-30 | — | — | US | disclosed |
| US-20250278034-A1 | EXTERNAL ADDITIVE FOR TONER AND TONER | CANON KABUSHIKI KAISHA (JP) | 2025-09-04 | — | — | US | disclosed |
| US-12360470-B2 | External additive for toner, toner and image forming apparatus | CANON KABUSHIKI KAISHA (JP) | 2025-07-15 | — | — | US | disclosed |
| EP-3674800-A1 | TONER AND METHOD FOR PRODUCING TONER | CANON KABUSHIKI KAISHA (JP) | 2020-07-01 | — | — | EP | disclosed |
| US-9645518-B2 | Toner | CANON KABUSHIKI KAISHA (JP) | 2017-05-09 | — | — | US | disclosed |
| US-9632441-B2 | Toner | CANON KABUSHIKI KAISHA (JP) | 2017-04-25 | — | — | US | disclosed |
| EP-2860584-B1 | Toner | CANON KK (JP) | 2017-04-05 | — | — | EP | disclosed |
| US-20160378003-A1 | MAGNETIC TONER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | CANON KABUSHIKI KAISHA (JP) | 2016-12-29 | — | — | US | disclosed |
| US-9529289-B2 | Method for producing toner particles | CANON KABUSHIKI KAISHA (JP) | 2016-12-27 | — | — | US | disclosed |
| US-20150378274-A1 | TONER | CANON KABUSHIKI KAISHA (JP) | 2015-12-31 | — | — | US | disclosed |
| US-20150378275-A1 | METHOD FOR PRODUCING TONER PARTICLES | CANON KABUSHIKI KAISHA (JP) | 2015-12-31 | — | — | US | disclosed |
| EP-2860584-A1 | Toner | Canon Kabushiki Kaisha (JP) | 2015-04-15 | — | — | EP | disclosed |
| US-20150099224-A1 | TONER | CANON KABUSHIKI KAISHA (JP) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260118791-A1 | TONER | MSR1, H1-2, TAAR1 | SMPD1 1729/4885TSHR 165/4885THRB 1009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.